- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: J&J to Show Drug Prices; SCOTUS Blocks Abortion Law; Democrats' Medicare Bill
Johnson & Johnson will become the first drug maker to begin showing the list price of its prescription drugs in television ads; in a 5-4 decision, the Supreme Court blocked a Louisiana law that required doctors performing abortions to have admitting privileges at nearby hospitals; Democrats unveiled a bill to allow Medicare to negotiate drug prices.
J&J to Start Listing Drug Prices in TV Ads, Starting With Xarelto
Johnson & Johnson will become the first drug maker to begin showing the list price of its prescription drugs in television ads, the Associated Press reported. The first drug it will start with is its blood thinner Xarelto. By late March, commercials will give the pill’s list price plus typical out-of-pocket costs.
High Court Blocks Louisiana Abortion Law
In a 5-4 decision, the Supreme Court blocked a Louisiana law that required doctors performing abortions to have admitting privileges at nearby hospitals, The New York Times reported. Opponents of the law said it could have left the state with just 1 doctor authorized to provide abortions. Chief Justice John G. Roberts Jr joined the court’s 4-member liberal wing.
Democrats Unveil Bill Requiring Medicare to Negotiate Drug Prices
Led by Senator Sherrod Brown, D-Ohio, who is considering a presidential run, Democrats unveiled a bill to allow Medicare to negotiate drug prices, a key part of their agenda to lower pharmaceutical costs. Joined by Representative Lloyd Doggett, D-Texas, the chairman of the House Ways and Means Health Subcommittee, Brown said he hoped that President Trump would listen to “candidate Trump,” referring to when Trump said during his campaign that he supported the idea, before reversing his position. The bill has long odds of passage, The Hill noted.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
